Diffúz nagy B-sejtes limfóma (DLBCL): vizsgálatok itt: Egyesült Államok

In Egyesült Államok 131 Also abroad 346

131 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Where
Albany, Alexandria, Ann Arbor, Athens, Belleville, Bethesda, Billings, Bridgeton, Charlottesville, Cincinnati, Clermont, Columbia, Dallas, Detroit, Eugene, Fargo, Fort Wayne, Fullerton, Gilbert, Golden, Grand Rapids, Greenville, Hampton, Hialeah, Hinsdale, Houston, Jackson, Kansas City, Knoxville, Las Vegas, Lexington, Long Beach, Los Alamitos, Los Angeles, Louisville, Lubbock, Madison, Mobile, Naperville, Nashville, New York, Ocoee, O'Fallon, Olympia, Orange City, Owensboro, Phoenix, Portland, Reno, Richmond, Roanoke, Saginaw, San Francisco, Shirley, Sioux Falls, Springfield, Tampa, The Woodlands, Topeka, Tucson
Életkor
18 év and over
People
1046 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06717347 · EU 2024-515566-13-00
2. fázisTaking people
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Where
Albany, Anchorage, Aurora, Baton Rouge, Boise, Boston, Chattanooga, Clovis, East Syracuse, Eugene, Fairfax, Fullerton, Gainesville, Glendale, Grand Rapids, Lexington, Los Angeles, Miami, Nashville, Omaha, Orlando, Panorama City, Portland, San Francisco, Swansea, Tacoma, Temple, The Woodlands, Torrance, Tyler, Virginia Beach, Waukee
Életkor
18 év and over
People
130 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00
1/2. fázisTaking people
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
Where
Irvine, Nashville
Életkor
18 év and over
People
274
Run by
Umoja Biopharma
See details and how to joinNCT07735533
1/2. fázisTaking people
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Where
Bethesda
Életkor
18 év to 120 év
People
155
Run by
National Cancer Institute (NCI)
See details and how to joinNCT03223610
No phaseCsak meghívásos
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
Where
Bethesda
Életkor
3 év to 65 év
People
120
Run by
National Cancer Institute (NCI)
See details and how to joinNCT03226704
2. fázisTaking people
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Where
Bethesda
Életkor
18 év and over
People
132
Run by
National Cancer Institute (NCI)
See details and how to joinNCT04002947
2. fázisTaking people
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Where
Ames, Anaconda, Ankeny, Ashland, Bellevue, Bethesda, Billings, Boone, Bozeman, Brainerd, Buffalo, Burlington, Canton, Carroll, Cedar Rapids, Charlottesville, Chicago, Cincinnati, City of Saint Peters, Cleveland, Clive, Coeur d'Alene, Columbus, Creve Coeur, Crown Point, Danville, Deer River, DeKalb, Derby, Des Moines, Duluth, Durham, Dyer, Effingham, Escanaba, Fargo, Fort Dodge, Geneva, Glenview, Grayslake, Great Falls, Green Bay, Guilford, Hibbing, Hobart, Hood River, Indianapolis, Janesville, Jefferson, Kalispell, La Crosse, Lake Forest, Los Angeles, Madison, Manistique, Marshalltown, Mattoon, Menomonee Falls, Milwaukee, Missoula, Mukwonago, Munster, Newberg, New Berlin, New Haven, New Orleans, Normal, Oak Brook, Oak Creek, Oconomowoc, Oconto Falls, Oklahoma City, Omaha, Oregon City, Orland Park, Philadelphia, Portland, Post Falls, Richmond, Sandpoint, Sandstone, Seattle, Sheboygan, Shiloh, Spooner, St Louis, Sturgeon Bay, Superior, Tucson, Urbana, Valparaiso, Virginia, Warrenville, Waukee, Waukesha, West Bend, West Chester
Életkor
18 év and over
People
120
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06649812
2. fázisNot yet taking people in Egyesült Államok
MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma
Where
Omaha
Életkor
19 év and over
People
50
Run by
University of Nebraska
See details and how to joinNCT07517705
2. fázisNot yet taking people in Egyesült Államok
The CARDIOPROTECT Trial
Where
Boston
Életkor
18 év and over
People
60
Run by
Beth Israel Deaconess Medical Center
See details and how to joinNCT07654426
1. fázisTaking people
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
Where
Rockville
Életkor
18 év and over
People
15
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07649304
2. fázisTaking people
Auto Stem Cell Transplant for Lymphoma Patients
Where
Minneapolis
Életkor
Up to 75 év
People
150
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03125642
3. fázisTaking people
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Where
Baltimore, Boston, Cleveland, Detroit, Durham, Grand Rapids, Greenville, Houston, Indianapolis, Jacksonville, Lexington, Los Angeles, New Brunswick, Noblesville, Ogden, Orange, Rochester, Sacramento, Scottsdale, Stony Brook, Waukesha, Westbury
Életkor
18 év and over
People
904 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT06091865 · EU 2022-502785-25-00
3. fázisTaking people
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Where
Albuquerque, Atlanta, Aurora, Austin, Boston, Buffalo, Chicago, Cincinnati, Cleveland, Denver, Durham, Fort Worth, Gilbert, Hackensack, Houston, Iowa City, Jacksonville, Little Rock, Los Angeles, Louisville, Milwaukee, Morristown, Nashville, Norfolk, Omaha, Orange, Orlando, Pittsburgh, Richmond, Rochester, Salt Lake City, San Antonio, Scottsdale, Tampa, Washington D.C., Westwood, Winston-Salem
Életkor
18 év and over
People
400 worldwide
Run by
Lyell Immunopharma, Inc.
See details and how to joinNCT07188558
1. fázisTaking people
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Where
Atlanta, Boston, Columbus, Dallas, Denver, Duarte, Houston, Los Angeles, Miami, Milwaukee, Nashville, New York, Portland, Rochester, San Francisco, Sarasota, Scottsdale, Seattle
Életkor
18 év and over
People
460 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00
2/3. fázisTaking people
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Where
Baltimore, Beverly Hills, Billings, Boca Raton, Boston, Clermont, Edgewood, Glendale, Grand Island, Grand Rapids, Hialeah, Horsham, Knoxville, Las Vegas, Lexington, Louisville, Morristown, Nashville, Niles, Omaha, Rio Rancho, Roanoke, Valhalla, Walnut Creek, Whittier, Worcester
Életkor
18 év and over
People
290 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT05139017 · EU 2022-502646-27-00
1. fázisTaking people
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Where
Baltimore
Életkor
18 év and over
People
140 worldwide
Run by
Iksuda Therapeutics Ltd.
See details and how to joinNCT05365659
No phaseTaking people
Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
Where
Boston, Hackensack, Honolulu, Houston, Louisville
Életkor
10 év and over
People
210 worldwide
Run by
Leuko Labs, Inc.
See details and how to joinNCT06323447
2. fázisTaking people
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Where
Amarillo, Aurora, Austin, Baton Rouge, Boca Raton, Boston, Bozeman, Buffalo, Burbank, Burnsville, Chandler, Chapel Hill, Charleston, Charlotte, Chicago, Cincinnati, Cleveland, Dallas, Duarte, Edgewood, Elizabethtown, Glendale, Goodyear, Grand Junction, Hot Springs, Iowa City, Jacksonville, Knoxville, La Jolla, Lexington, Lincoln, Louisville, Madison, Manassas, Mayfield Heights, Miami Beach, Milwaukee, Mineola, Mobile, Monroe, Morristown, Murray, Nashville, Newark, New Orleans, New York, Omaha, Orange City, Palestine, Paramus, Peoria, Philadelphia, Portland, Post Falls, Richmond, San Antonio, Sellersville, Shreveport, St. George, Syracuse, Tyler, Vancouver, Walnut Creek, Washington D.C., Waukee, Westbury, Winston-Salem, York
Életkor
18 év and over
People
594 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06890884 · EU 2024-515526-89-00
1. fázisTaking people
A Study of ARC-02 in B-cell NHL
Where
Charlotte, Los Angeles, Louisville, Milwaukee, Richmond, Spokane
Életkor
18 év and over
People
140 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00
2. fázisTaking people
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
Where
Beltsville, Berkeley, Des Moines, Detroit, Jacksonville, La Jolla, Lexington, Lubbock, Olympia, Orange, Sioux Falls, Stamford, Tacoma, Towson
Életkor
65 év to 99 év
People
80 worldwide
Run by
AstraZeneca
See details and how to joinNCT05952024
1/2. fázisTaking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Aurora, Boston, Fargo, Grand Rapids, Houston, Iowa City, Kansas City, Los Angeles, New Brunswick, New Haven, New York, Philadelphia, Portland, Salt Lake City, Sioux Falls, St. Petersburg, Valhalla
Életkor
6 hónap to 25 év
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
2. fázisTaking people
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Where
Atlanta, Augusta, Austin, Baltimore, Berkeley, Bethesda, Boston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Dallas, Duarte, Durham, East Brunswick, Eugene, Fairfax, Fort Wayne, Gilbert, Hackensack, Hot Springs, Houston, Indianapolis, Kansas City, Lexington, Lone Tree, Los Angeles, Louisville, Miami, Minneapolis, Nashville, Newark, New Brunswick, New York, Norfolk, Orlando, Philadelphia, Pittsburgh, Portland, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Springfield, St Louis, Tampa, Tyler, Washington D.C.
Életkor
18 év and over
People
250 worldwide
Run by
Allogene Therapeutics
See details and how to joinNCT06500273
2. fázisTaking people
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
Where
Basking Ridge, Commack, Hackensack, Harrison, Middletown, Montvale, New York, Rockville Centre
Életkor
65 év to 80 év
People
42
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06765317
No phaseTaking people
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Where
Atlanta, Aurora, Cincinnati, Houston, Milwaukee, Philadelphia
Életkor
0 év to 38 év
People
30
Run by
Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT06131801
No phaseTaking people
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Where
Chapel Hill
Életkor
18 év to 120 év
People
15 000
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT01137643